Koninklijke Philips (NYSE:PHG) Shares Bought by Park Avenue Securities LLC

Park Avenue Securities LLC lifted its position in shares of Koninklijke Philips (NYSE:PHG - Free Report) by 76.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 35,036 shares of the technology company's stock after buying an additional 15,169 shares during the quarter. Park Avenue Securities LLC's holdings in Koninklijke Philips were worth $890,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in PHG. Colonial Trust Co SC lifted its stake in shares of Koninklijke Philips by 724.0% during the 4th quarter. Colonial Trust Co SC now owns 1,409 shares of the technology company's stock worth $36,000 after purchasing an additional 1,238 shares during the last quarter. Farther Finance Advisors LLC lifted its stake in shares of Koninklijke Philips by 37.1% during the 4th quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company's stock worth $54,000 after purchasing an additional 582 shares during the last quarter. Whipplewood Advisors LLC purchased a new stake in shares of Koninklijke Philips during the 4th quarter worth $55,000. Millstone Evans Group LLC purchased a new stake in shares of Koninklijke Philips during the 4th quarter worth $60,000. Finally, Allworth Financial LP lifted its stake in shares of Koninklijke Philips by 24.9% during the 4th quarter. Allworth Financial LP now owns 3,993 shares of the technology company's stock worth $105,000 after purchasing an additional 797 shares during the last quarter. Institutional investors own 13.67% of the company's stock.

Koninklijke Philips Stock Performance

Shares of Koninklijke Philips stock traded down $0.88 on Friday, reaching $22.74. 798,766 shares of the stock were exchanged, compared to its average volume of 883,418. The business has a 50 day moving average price of $23.80 and a two-hundred day moving average price of $25.29. The firm has a market capitalization of $21.38 billion, a price-to-earnings ratio of -27.07, a PEG ratio of 0.82 and a beta of 0.76. Koninklijke Philips has a twelve month low of $20.61 and a twelve month high of $31.57. The company has a quick ratio of 0.74, a current ratio of 1.23 and a debt-to-equity ratio of 0.59.

Koninklijke Philips (NYSE:PHG - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The technology company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.13. Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. The company had revenue of $4.31 billion for the quarter, compared to the consensus estimate of $4.10 billion. During the same quarter in the prior year, the company earned $0.21 EPS. Koninklijke Philips's quarterly revenue was down 1.0% on a year-over-year basis. Analysts anticipate that Koninklijke Philips will post 1.63 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. Wall Street Zen cut Koninklijke Philips from a "buy" rating to a "hold" rating in a research note on Sunday. Sanford C. Bernstein upgraded Koninklijke Philips from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, March 18th. UBS Group upgraded Koninklijke Philips from a "neutral" rating to a "buy" rating in a research note on Thursday, February 20th. Finally, BNP Paribas upgraded Koninklijke Philips from a "neutral" rating to an "outperform" rating in a research note on Tuesday, February 25th. Two equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy".

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.